Drug trials in pediatric oncology: A multi-facetted problem

International Journal of Clinical Pharmacology and Therapeutics

Volumn 36, Issue 11, 1998, Pages 613-620

  Boos, J ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Clinical drug trials; Clinical trials; Drug investigation; Pediatric oncology

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT;

CHILD; CHILDHOOD CANCER; CONFERENCE PAPER; DRUG RESEARCH; GERMANY; HUMAN; LEGAL ASPECT; MEDICAL ETHICS; PATIENT SELECTION;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; DRUG EVALUATION; ETHICS, MEDICAL; GERMANY; HUMANS; INFANT; NEOPLASMS; PEDIATRICS;

EID: 0031772626     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Beck JD, Winkler K, Niethammer D, Brandis M, Hertzberg H, von der Hardt K, Greil J, Überall M, Rossi R, Lumprecht-Dinnesen A, Brämswig J, Kaatsch P, Michaelis J, Meier W, Hausdorf M, Bielack S, Dörr HG 1995 Die Nachsorge der von einer Krebserkrankung geheilten Kinder und jungen Erwachsenen. Erste Empfehlungen der Arbeitsgemeinschaft Spätfolgen. Klin Pädiatr 207: 186-192
2. Carlson L, Ho P, Smith M, Reisch J, Weitman S 1996 Pediatric phase I drug tolerance: a review and comparison of recent adult and pediatric phase I trials. J Pediatr Hematol Oncol 18: 250-256
3. Collins JM, Grieshaber CK, Chabner BA 1990 Pharmacologically guided phase I clinical trials based upon preclinical drug development. J Natl Cancer Inst 82: 1321-1326
4. Decoster G, Stein G, Holdener EE 1989 Responses and toxic deaths in Phase I clinical trials. Ann Oncol 1: 175-181
5. Deutsch E 1991 Arztrecht und Arzneimittelrecht. Springer, Berlin
6. Grodin MA, Glantz LH 1994 Children as Research Objects - Science, Ethics and Law. Oxford University Press, New York
7. Kaatsch P, Kaletsch U, Michaelis J 1997 Jahresbericht 1996 des Deutschen Kinderkrebsregisters. Institut für Med. Statistik und Dokumentation, Universität, Mainz
8. Kaatsch P, Michaelis J 1995 Zweitmalignome nach malignen Erkrankungen im Kindesalter. Klin Pädiatr 207: 158-163
9. Kienle G 1974 Arzneimittelsicherheit und Gesellschaft - Eine kritische Untersuchung. Schattauer, Stuttgart
10. Koch HJ, Klug B 1998 Ethische Prinzipien für klinische Prüfungen bei Kindern und Jugendlichen. Monatsschr Kinderheilkd 146: 342-346
11. Koren G 1993 Textbook of Ethics in Pediatric Research. Krieger Publishing, Malbar, Florida
12. Marsoni S, Ungerleider KS, Hurson SB, Simon RM, Hammershaimb LD 1985 Tolerance to antineoplastic agents in children and adults. Cancer Treat Rep 69: 1263-1269
13. Melink TJ, Clark GM, Von Hoff DD 1992 The impact of phase I clinical trials on the quality of life of patients with cancer. Anticancer Drugs 3: 571-576
14. O'Gady J, Joubert PH 1997 Handbook of phase I/II clinical drug trials. CRC Press, Boca Raton, p 69-70, p 109
15. Ratain MJ, Collyar D, Kamen BA, Eisenhauer E, Lawrence TS, Runowicz C, Turner S, Wade JL (Subcommitee on Phase I Clinical Trials) 1997 Critical role of phase I clinical trials in cancer treatment. J Clin Oncol 15: 853-859
16. Ratain MJ, Mick R, Schlilsky RL, Siegler M 1993 Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents. J Natl Cancer Inst 85: 1637-1643
17. Schellong G, Brämswig JH, Hörnig-Franz I 1992 Treatment of children with Hodgkin's disease - Results of the German Pediatric Oncology Group. Ann Oncol 3 (Suppl 4): 73-76
18. Smith M, Bernstein M, Bleyer A, Borsi J, Ho P, Lewis I, Pearson A, Pein F, Pratt C, Reaman G, Riccardi R, Seibel N, Trueworthy K, Ungerleider R, Vassal G, Vietti R 1998 Conduct of phase I trials in children with cancer. J Clin Oncol 16: 966-978
19. Von Hoff DD 1996 Is response in phase I trials a useful predictor for the future clinical activity of a new agent? Ann Oncol 7 (Suppl 1): 14
20. Wagner W 1993 Arzneimittel und Verantwortung. Springer, Berlin
21. Winkler K, Beron G, Delling G, Heise U, Kabisch H, Purfürst C, Berger J, Ritter J, Jürgens H, Gerein V, Graf N, Russe W, Gruemayer ER, Ertelt W, Kotz R, Preusser P, Prindull G, Brandeis W, Landbeck G 1988 Neoadjuvant chemotherapy of osteosarkoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 6: 329-337